Unicentric Comparing Study of Suction Curettage With Standard BOTOX Injection in the Treatment of Patients With Essential Axillar Hyperhidrosis: Comparing of Efficacy, Duration of Effectiveness, and Adverse Events.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00669474|
Recruitment Status : Terminated (Study never started)
First Posted : April 30, 2008
Last Update Posted : June 4, 2015
Part 1: patients with essential hyperhidrosis are treated one time with suction curettage in both axillae.
Part 2: patients with axillary hyperhidrosis receive one treatment with suction curettage in one axilla, and at the same time one treatment with BOTOX injections in the other axilla.
|Condition or disease||Intervention/treatment||Phase|
|Essential Axillary Hyperhidrosis||Procedure: Suction curettage Drug: Treatment with Botox||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||25 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Unicentric Comparing Study of Suction Curettage With Standard BOTOX Injection in the Treatment of Patients With Essential Axillar Hyperhidrosis: Comparing of Efficacy, Duration of Effectiveness, and Adverse Events.|
|Study Start Date :||June 2009|
|Actual Primary Completion Date :||August 2011|
|Actual Study Completion Date :||August 2011|
Procedure: Suction curettage
Active Comparator: 2
Treatment with Botox
Drug: Treatment with Botox
Treatment with Botox
- Effectiviness and duration of effect of both treatments [ Time Frame: 1 year ]
- Adverse events of both treatments [ Time Frame: 1 year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00669474
|University Hospital Ghent|
|Ghent, Belgium, 9000|
|Principal Investigator:||Katia Ongenae, MD, PhD||University Hospital, Ghent|